Related content

Raloxifene administration in post‐menopausal women with osteoporosis: effect of different Bsm I vitamin D receptor genotypes

By Palomba Stefano  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 192-198

Oxford University Press

Access to resources Recommend Favorite

Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

By Rackoff Paula J.   Sebba Anthony  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Percutaneous administration of testosterone gel in postmenopausal women – a pharmacological study

By Nathorst-böös Jörgen   Jarkander-Rolff Maria   Carlström Kjell   Flöter Angelique   von Schoultz Bo  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 243-248

Informa Healthcare

Access to resources Recommend Favorite

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women

By Essen Huib   Holzmann Paulien   Blankenstein Marinus   Lips Paul   Bravenboer Nathalie  

Calcified Tissue International, Vol. 81, Iss. 3, 2007-09 ,pp. : 183-190

Springer Publishing Company

Access to resources Recommend Favorite

Uterine first pass effect in postmenopausal women

By Einer-Jensen N.  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3060-3064

Oxford University Press

Access to resources Recommend Favorite